Mauna Kea Tech Stock
Price
Target price
€0.36
€0.36
0.700%
0.0025
0.700%
-
19.07.24 / Frankfurt
WKN: A1JCLA / Name: Mauna Kea / Stock / Healthcare Equipment & Supplies / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Mauna Kea Tech Stock
The Mauna Kea Tech stock is trending slightly upwards today, with an increase of €0.003 (0.700%) compared to yesterday's price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Mauna Kea Tech stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Mauna Kea Tech in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Mauna Kea Tech vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Mauna Kea Tech | 0.700% | 5.394% | 2.991% | -40.931% | -18.120% | -64.066% | -79.104% |
Intrasense | -2.830% | 2.612% | 7.422% | -36.927% | -15.902% | -57.594% | - |
InVivo Therapeutics Holdings | -2.480% | 9.790% | -6.548% | -71.964% | -54.360% | -99.934% | -99.934% |
Atossa Genetics Inc | 0.160% | 11.232% | 17.850% | 21.464% | 30.499% | -65.889% | -67.201% |
News
![Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances: https://mms.businesswire.com/media/20240626399128/en/337855/5/mkt_logo_bg_1024-300dpi.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBekhFYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--3f16fce5b447747b8a7f3fe8cab92cedd6ff35e6/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/mkt_logo_bg_1024-300dpi.jpg?locale=us)
Mauna Kea Technologies Unveils CellTolerance, a Subsidiary Dedicated to its Unique Program for the Detection and Treatment of Food Intolerances
Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary platform for probe-based and needle-based confocal laser endomicroscopy (p/nCLE)